Revised press release for the financial results for the quarter and nine months ended December 31, 2025 due to inadvertent missing out on the complete press release.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has re-issued its press release detailing financial results for the quarter and nine months ended December 31, 2025. The revision was made because the complete press release was inadvertently missed out in the earlier filing to the exchanges. Investors should treat this as the corrected, full version of the earnings release. No other business or operational changes are indicated.
Likely a routine administrative/clerical correction with no material change to underlying fundamentals, though shareholders should review the revised release to confirm whether any numbers differ from the original submission.